Multiple Sclerosis Research

Monash University's acclaimed Faculty of Medicine, Nursing and Health Science is raising funds for research into new therapeutic avenues for multiple sclerosis (MS), which could dramatically improve patient's lives and save billions of dollars on the cost of health care.

The research team from Monash University’s Faculty of Medicine, Nursing and Health Science – which harnesses the talent of internationally renowned academic leaders in multiple sclerosis, autoimmunology and stem-cell research - will endeavour to find a method to reverse the autoimmune process believed to trigger MS. Effectively, this research may lead to the cure of this degenerative disease. If successful, the research also could help patients suffering from other autoimmune diseases, such as insulin-dependent diabetes, as well as trauma and spinal cord injuries.

This distinguished team includes professors from the world-renowned Monash Immunology and Stem Cell Laboratories. It is headed by Professor Claude Bernard, a pre-eminent world expert in multiple sclerosis and autoimmune research; Professor Alan Trounson, internationally renowned for his research on stem cells; and Professor Richard Boyd, recognised for his work with stem cells, ageing and the immune system.

The Impact of MS

The "Access Economic Report on MS in Australia" states that 16,000 Australian have MS, a chronic and progressive disease of the central nervous system. MS is usually not fatal, however its' effects are devastating causing vision impairment, paralysis, poor coordination, fatigue and memory and concentration problems. The condition causes anxiety in sufferers as it is not know when a new attack will occur or if the effects will be lasting. It is predicted that the prevalence of MS will increase by nearly seven percent in the next five years. The estimated financial cost of MS in Australia each year is more than $600 million. Of those diagnosed, 3,200 people will not be able to work. The disease affects more women than men, with patients usually diagnosed between the ages of 20 and 40 when they are at the peak of building their families and careers. Household incomes are reduced whilst medical and other care expenses vastly increase. While MS exists in various degrees of severity, most patients advance to a state of chronic disability, causing huge financial and emotional burdens to patients and their families.

Contributions

Your contribution to this significant research will be gratefully received. Contributions can be made by post, telephone or fax, as follows:

MS Research
Monash University Medical Foundation
PO Box 64, Monash University
Melbourne VIC 3800

By telephone or fax:

Monash University Medical Foundation
Tel: +61 03 9905 9329
Fax: +61 03 9905 0750

Email enquiries can be made to: foundation@med.monash.edu.au